Vimarsana
Biggest News Aggregation in the World

Page 2 - Former Duran News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Former Duran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Former Duran Today - Breaking & Trending Today

Andy Taylor: New Cancer Drug to Extend Lifespan for Five Years - Vimarsana News

Andy Taylor: New Cancer Drug to Extend Lifespan for Five Years

Former Duran Duran guitarist revealed stage 4 prostate cancer diagnosis last year. Continue reading…

Source: whli.com
Related Topics:
Former Duran
Duran Duran's Andy Taylor Announces New Solo Album 'Man's A Wolf To Man' - Vimarsana News

Duran Duran's Andy Taylor Announces New Solo Album 'Man's A Wolf To Man'

Former Duran Duran guitarist Andy Taylor has announced that his new solo album, Man's A Wolf To Man, will be released on September 8. Man's A Wolf To Man comes more than three decades after Taylor released his second solo album, Dangerous. Taylor is battling stage-4 prostate cancer, which prevented

Source: kkgb.com
Duran Duran's Andy Taylor says new cancer treatment has added five years to his life – Easy 93.1 - Vimarsana News

Duran Duran's Andy Taylor says new cancer treatment has added five years to his life – Easy 93.1

Former Duran Duran guitarist Andy Taylor has shared a health update, and he's got a bit of good news.

Source: easy93.com
Andy Taylor: New Cancer Drug to Extend Lifespan for Five Years - Vimarsana News

Andy Taylor: New Cancer Drug to Extend Lifespan for Five Years

Former Duran Duran guitarist said he expected a new prostate cancer drug to extend his lifespan for five years in an August 2023 interview.

Source: wrkr.com
Andy Taylor: New Cancer Drug to Extend Lifespan for Five Years - Vimarsana News

Andy Taylor: New Cancer Drug to Extend Lifespan for Five Years

Former Duran Duran guitarist said he expected a new prostate cancer drug to extend his lifespan for five years in an August 2023 interview.